Intelligent Nanovector Delivery System

A novel system integrating nanovectors for targeted delivery of active substances with cutting-edge technologies such as AI, IoT, blockchain, and novel materials to enhance efficacy, safety, and transparency.

The original patent on nanovectors for delivering active substances in the body had limitations in terms of real-time monitoring, personalized treatment, and secure tracking. The new inventive concept addresses these limitations by synergistically combining the patented nanovectors with distinct technologies.

The Intelligent Nanovector Delivery System comprises a nanovector according to claim 1, a wearable IoT device for real-time monitoring and adjustment of active substance delivery, an AI-powered module for personalized treatment planning, a blockchain-based platform for secure tracking, and a biodegradable coating made of a novel, biocompatible material. The system enables targeted delivery, real-time monitoring, and secure tracking of nanovectors, ensuring enhanced efficacy, safety, and transparency.

The new claims introduce the innovative combination of nanovectors with AI, IoT, blockchain, and novel materials, which is non-obvious and novel compared to the original patent. The integration of these distinct technologies enables a more powerful and efficient system for targeted delivery of active substances.

Alternative embodiments may include the use of different AI algorithms, various IoT devices, or alternative blockchain platforms. Variations may also include the incorporation of other novel materials or the integration of additional technologies, such as robotics or augmented reality.

The Intelligent Nanovector Delivery System has significant commercial potential in the pharmaceutical and biotechnology industries, particularly in the areas of targeted cancer treatment, gene therapy, and vaccine development. The system's enhanced efficacy, safety, and transparency make it an attractive solution for healthcare providers and patients alike.